Dilaudid, also known as hydromorphone, is a potent opioid that is typically prescribed by a doctor for the treatment of moderate to severe pain. A single dose of Dilaudid will cost about $5 to $100 on the street, depending on the dosage.
Because opioids are so much more expensive on the street than at the pharmacy, the costs can add up quickly. A person abusing Dilaudid or another opioid might find themselves spending tens of thousands of dollars annually.
The street cost of prescription drugs is influenced by a number of factors such as the location of sale, local laws, supply and demand, and more.
What Factors Can Affect The Price Of Dilaudid?
The cost of Dilaudid on the street can vary significantly.
Dilaudid often has to be obtained by illegal means such as prescription forgery or robbery of pharmacies and nursing homes, and this can hike up the prices heavily in certain areas.
As with any drug bought and sold on the street, the price will be heavily influenced by where it’s sold, ease of acquisition, and local laws and regulations.
How Much Does A Tablet Of Dilaudid Cost On The Street?
Tablets of Dilaudid come in three sizes: 2 mg, 4 mg, or 8 mg.
Find An Addiction Treatment Program Today
Reach out to AddictionResource.net today for more helpful information about substance use disorder treatment.
If you or a loved one is living with an opioid addiction, contact our team today.
Addiction Resource aims to provide only the most current, accurate information in regards to addiction and addiction treatment, which means we only reference the most credible sources available.
These include peer-reviewed journals, government entities and academic institutions, and leaders in addiction healthcare and advocacy. Learn more about how we safeguard our content by viewing our editorial policy.
- Drug Enforcement Administration — Hydromorphone
https://www.deadiversion.usdoj.gov/drug_chem_info/hydromorphone.pdf - U.S. Association for the Study of Pain — Street prices of prescription opioids diverted to the illicit market: data from a national surveillance program
https://www.jpain.org/article/S1526-5900(13)00492-6/fulltext - U.S. Food and Drug Administration — Highlights of Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019891s024%2C019892s029lbl.pdf